Suppr超能文献

蜂类过敏原二肽基肽酶 IV 的结构相似性与交叉反应性——包括 一种新的二肽基肽酶 IV 序列的全面比较

Structural Similarities, in Relation with the Cross-Reactivity, of Hymenoptera Allergenic Dipeptidyl Peptidases IV-An Overall Comparison Including a New Dipeptidyl Peptidase IV Sequence from .

机构信息

Research and Development, Alk-Abelló A.S., 28037 Madrid, Spain.

Global Research, ALK-Abelló A/S., 2970 Hørsholm, Denmark.

出版信息

Toxins (Basel). 2023 Nov 14;15(11):656. doi: 10.3390/toxins15110656.

Abstract

(1) Background: Dipeptidyl Peptidases IV (DPPIVs), present in many organisms, are minor components in the venoms of Hymenoptera, where they have been identified as cross-reactive allergenic molecules. Considering that the structure of homologous DPPIVs is well characterized, we aimed to explain which regions have higher similarity among these proteins and present a comparison among them, including a new DPPIV sequence. Moreover, two cases of sensitization to DPPIVs in wasp- and honeybee-sensitized patients are presented. (2) Methods: Proteomic analyses have been performed on the venom of the Asian hornet to demonstrate the sequence of its DPPIV (allergen named Vesp v 3, with sequence accession number P0DRB8, and with the proteomic data available via ProteomeXchange with the identifier PXD046030). A comparison performed through their alignments and analysis of the three-dimensional structure showed a region with higher similarity among Hymenoptera DPPIVs. Additionally, ImmunoCAP™ determinations (including specific inhibition experiments), as well as IgE immunoblotting, are performed to demonstrate the allergenicity of Api m 5 and Ves v 3. (3) Results and Conclusions: The data presented demonstrate that the similarities among Hymenoptera DPPIVs are most likely localized at the C-terminal region of these enzymes. In addition, a higher similarity of the / DPPIVs is shown. The clinical cases analyzed demonstrated the allergenicity of Api m 5 and Ves v 3 in the sera of the allergic patients, as well as the presence of this minor component in the preparations used in venom immunotherapy.

摘要

(1)背景:二肽基肽酶 IV(DPPIVs)存在于许多生物体中,是膜翅目毒液中的次要成分,已被鉴定为交叉反应性过敏原分子。考虑到同源 DPPIVs 的结构特征良好,我们旨在解释这些蛋白质之间哪些区域具有更高的相似性,并对它们进行比较,包括新的 DPPIV 序列。此外,还介绍了两种对黄蜂和蜜蜂过敏患者中 DPPIV 过敏的情况。(2)方法:对亚洲大黄蜂毒液进行蛋白质组学分析,以证明其 DPPIV 的序列(过敏原命名为 Vesp v 3,序列登录号为 P0DRB8,并通过 ProteomeXchange 提供蛋白质组数据,标识符为 PXD046030)。通过它们的比对和三维结构分析进行比较,显示出膜翅目 DPPIV 之间具有更高相似性的区域。此外,进行 ImmunoCAP™测定(包括特异性抑制实验)以及 IgE 免疫印迹,以证明 Api m 5 和 Ves v 3 的变应原性。(3)结果与结论:所呈现的数据表明,膜翅目 DPPIV 之间的相似性很可能位于这些酶的 C 末端区域。此外,还显示了更高的 / DPPIVs 相似性。分析的临床病例表明,Api m 5 和 Ves v 3 在过敏患者的血清中具有变应原性,以及该次要成分存在于用于毒液免疫治疗的制剂中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49db/10675595/533939c60001/toxins-15-00656-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验